TA
TXMD icon

Tectonic Advisors’s TherapeuticsMD TXMD Stock Holding History

Tectonic Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,700
Closed -$101K – 230
2021
Q2 		$101K Hold
1,700
– – 0.02% 185
2021
Q1 		$114K Buy
1,700
+300
+21% +$23.5K 0.03% 174
2020
Q4 		$85K Buy
+1,400
New +$95.6K 0.02% 167

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tectonic Advisors's TXMD Position: Q3 2021 in Review

Tectonic Advisors sold out of TherapeuticsMD (TXMD) in Q3 2021, closing a stake of 1,700 shares — an estimated $101K sold.

Tectonic Advisors first reported a position in TXMD in Q4 2020 and held it in 3 quarters. The position peaked at $114K in Q1 2021. 149 funds tracked by Wall St. Rank hold TXMD as of Q3 2021.

  • Tectonic Advisors reported no remaining TherapeuticsMD position as of Q3 2021 after selling out during the quarter.
  • Tectonic Advisors sold 1,700 TherapeuticsMD shares in Q3 2021, an estimated $101K.
  • Tectonic Advisors first reported a position in TherapeuticsMD in Q4 2020 and held it in 3 quarters.
  • Tectonic Advisors's TherapeuticsMD position peaked at $114K in Q1 2021.
  • 149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2021.

Based on Tectonic Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.